SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness [video] [open html - 0B]
From the Webpage: "Perhaps now more than ever, it is undeniable how integral vaccines have become to public health. Vaccines protect us from a whole host of infectious diseases, including chickenpox, measles and the seasonal flu. With a new threat at hand, scientists at the NIH [National Institutes of Health] swiftly developed a vaccine candidate against the novel coronavirus that causes COVID-19 [coronavirus disease 2019]. The pre-clinical effort was driven in part by Dr. Kizzmekia Corbett." The duration of this video is 1 hour, 1 minute and 1 second.
National Institutes of Health
NIH VideoCasting: https://videocast.nih.gov/